Erika C. Claud to NF-kappa B
This is a "connection" page, showing publications Erika C. Claud has written about NF-kappa B.
Connection Strength
0.902
-
Oral administration of transforming growth factor-ß1 (TGF-ß1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor ?B (NF-?B) signaling and proinflammatory cytokine production. J Biol Chem. 2013 Nov 29; 288(48):34757-66.
Score: 0.368
-
Developmentally regulated tumor necrosis factor-alpha induced nuclear factor-kappaB activation in intestinal epithelium. Am J Physiol Gastrointest Liver Physiol. 2007 May; 292(5):G1411-9.
Score: 0.232
-
Transcriptional modulation of intestinal innate defense/inflammation genes by preterm infant microbiota in a humanized gnotobiotic mouse model. PLoS One. 2015; 10(4):e0124504.
Score: 0.102
-
Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury. PLoS One. 2013; 8(5):e65108.
Score: 0.089
-
Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function. Inflamm Bowel Dis. 2009 Oct; 15(10):1537-47.
Score: 0.070
-
Administration of defined microbiota is protective in a murine Salmonella infection model. Sci Rep. 2015 Nov 04; 5:16094.
Score: 0.027
-
Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol. 2007 Sep; 171(3):882-92.
Score: 0.015